Regulus Therapeutics Inc (RGLS) — Working Capital to Net Assets Ratio
Regulus Therapeutics Inc (RGLS) has a Working Capital to Net Assets ratio of 97.5% as of March 2025. Working capital of $67.30 Million (current assets of $71.69 Million minus current liabilities of $4.40 Million) is measured against net assets of $69.03 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See how many days can Regulus Therapeutics Inc fund operations to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Regulus Therapeutics Inc Working Capital to Net Assets (2010–2024)
This chart shows how Regulus Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 15 annual periods from 2010 to 2024. As of March 2025, the ratio stands at 97.5%, reflecting working capital of $67.30 Million against net assets of $69.03 Million USD. For the complete balance sheet picture, see balance sheet size of Regulus Therapeutics Inc.
Annual Working Capital to Net Assets for Regulus Therapeutics Inc (2010–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Regulus Therapeutics Inc from 2010 to 2024, covering 15 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check RGLS asset resilience ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 98.0% | $74.85 Million | $76.41 Million | $82.34 Million | $7.50 Million | ▲ +5.1 pp |
| 2023 | 92.8% | $19.67 Million | $21.19 Million | $28.18 Million | $8.51 Million | ▼ -4.5 pp |
| 2022 | 97.4% | $32.42 Million | $33.29 Million | $44.08 Million | $11.66 Million | ▼ -11.8 pp |
| 2021 | 109.2% | $60.01 Million | $54.96 Million | $65.23 Million | $5.23 Million | ▲ +12.5 pp |
| 2020 | 96.6% | $25.15 Million | $26.03 Million | $36.73 Million | $11.58 Million | ▲ +2.7 pp |
| 2019 | 94.0% | $18.81 Million | $20.02 Million | $40.41 Million | $21.60 Million | ▼ -31.6 pp |
| 2018 | 125.6% | $-7.35 Million | $-5.85 Million | $19.30 Million | $26.65 Million | ▲ +28.6 pp |
| 2017 | 96.9% | $34.14 Million | $35.22 Million | $66.74 Million | $32.60 Million | ▼ -34.6 pp |
| 2016 | 131.5% | $73.74 Million | $56.08 Million | $87.47 Million | $13.73 Million | ▲ +32.5 pp |
| 2015 | 99.0% | $122.82 Million | $124.08 Million | $134.26 Million | $11.44 Million | ▼ -19.4 pp |
| 2014 | 118.4% | $156.25 Million | $132.01 Million | $164.95 Million | $8.70 Million | ▼ -1.2 pp |
| 2013 | 119.5% | $111.70 Million | $93.46 Million | $117.18 Million | $5.48 Million | ▼ -19.2 pp |
| 2012 | 138.8% | $86.16 Million | $62.09 Million | $98.93 Million | $12.77 Million | ▲ +201.0 pp |
| 2011 | -62.2% | $25.82 Million | $-41.49 Million | $38.67 Million | $12.85 Million | ▼ -568.0 pp |
| 2010 | 505.8% | $40.45 Million | $8.00 Million | $55.17 Million | $14.73 Million | — |